Evaluating the in vitro and in vivo efficacy of nano-structured polymers for bladder tissue replacement applications

Megan Pattison, Thomas J. Webster, Jeffrey Leslie, Martin Kaefer, Karen M. Haberstroh

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Bladder cancers requiring radical cystectomy, along with congenital and acquired disorders which result in obstruction of the bladder, necessitate surgical measures (including augmentation); such diagnoses bring a clinical need for effective bladder replacement implant designs. Many recent approaches for the design of soft tissue replacement materials have relied on the use of synthetic polymeric substances; unfortunately, the optimal soft tissue implant material is yet to be found. This may, in part, be because current polymeric formulations fail to sufficiently biomimic the neighboring bladder tissue. This study took a brand new approach in designing the next generation of tissue-engineered bladder constructs through the use of nanotechnology, or materials with nanometer (less than 100 nm) surface features. Results provided evidence that nano-structured polymeric scaffolds (specifically, PLGA and PU) created using chemical etching techniques are capable of enhancing the human bladder smooth muscle cell adhesion, proliferation, and the production of extracellular matrix (ECM) proteins. Preliminary in vivo results also speak to the usefulness of such nano-structured materials. In combination, these findings suggest that nano-dimensional PLGA and PU scaffolds are promising replacement materials for the human bladder wall. (Figure Presented)

Original languageEnglish
Pages (from-to)690-700
Number of pages11
JournalMacromolecular Bioscience
Volume7
Issue number5
DOIs
StatePublished - May 10 2007

Fingerprint

Polymers
Urinary Bladder
Tissue
Scaffolds
Extracellular Matrix Proteins
Cell adhesion
Nanotechnology
Nanostructured materials
Muscle
Etching
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Cystectomy
Proteins
Urinary Bladder Neoplasms
Cell Adhesion
Smooth Muscle Myocytes
In Vitro Techniques
Cell Proliferation
polylactic acid-polyglycolic acid copolymer

Keywords

  • Biodegradable
  • Bladder
  • In vitro
  • In vivo
  • Nanotechnology

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Biomaterials
  • Polymers and Plastics
  • Materials Chemistry
  • Bioengineering

Cite this

Evaluating the in vitro and in vivo efficacy of nano-structured polymers for bladder tissue replacement applications. / Pattison, Megan; Webster, Thomas J.; Leslie, Jeffrey; Kaefer, Martin; Haberstroh, Karen M.

In: Macromolecular Bioscience, Vol. 7, No. 5, 10.05.2007, p. 690-700.

Research output: Contribution to journalArticle

Pattison, Megan ; Webster, Thomas J. ; Leslie, Jeffrey ; Kaefer, Martin ; Haberstroh, Karen M. / Evaluating the in vitro and in vivo efficacy of nano-structured polymers for bladder tissue replacement applications. In: Macromolecular Bioscience. 2007 ; Vol. 7, No. 5. pp. 690-700.
@article{9e0bf51a21674923a75897bdef4aa7fb,
title = "Evaluating the in vitro and in vivo efficacy of nano-structured polymers for bladder tissue replacement applications",
abstract = "Bladder cancers requiring radical cystectomy, along with congenital and acquired disorders which result in obstruction of the bladder, necessitate surgical measures (including augmentation); such diagnoses bring a clinical need for effective bladder replacement implant designs. Many recent approaches for the design of soft tissue replacement materials have relied on the use of synthetic polymeric substances; unfortunately, the optimal soft tissue implant material is yet to be found. This may, in part, be because current polymeric formulations fail to sufficiently biomimic the neighboring bladder tissue. This study took a brand new approach in designing the next generation of tissue-engineered bladder constructs through the use of nanotechnology, or materials with nanometer (less than 100 nm) surface features. Results provided evidence that nano-structured polymeric scaffolds (specifically, PLGA and PU) created using chemical etching techniques are capable of enhancing the human bladder smooth muscle cell adhesion, proliferation, and the production of extracellular matrix (ECM) proteins. Preliminary in vivo results also speak to the usefulness of such nano-structured materials. In combination, these findings suggest that nano-dimensional PLGA and PU scaffolds are promising replacement materials for the human bladder wall. (Figure Presented)",
keywords = "Biodegradable, Bladder, In vitro, In vivo, Nanotechnology",
author = "Megan Pattison and Webster, {Thomas J.} and Jeffrey Leslie and Martin Kaefer and Haberstroh, {Karen M.}",
year = "2007",
month = "5",
day = "10",
doi = "10.1002/mabi.200600297",
language = "English",
volume = "7",
pages = "690--700",
journal = "Macromolecular Bioscience",
issn = "1616-5187",
publisher = "Wiley-VCH Verlag",
number = "5",

}

TY - JOUR

T1 - Evaluating the in vitro and in vivo efficacy of nano-structured polymers for bladder tissue replacement applications

AU - Pattison, Megan

AU - Webster, Thomas J.

AU - Leslie, Jeffrey

AU - Kaefer, Martin

AU - Haberstroh, Karen M.

PY - 2007/5/10

Y1 - 2007/5/10

N2 - Bladder cancers requiring radical cystectomy, along with congenital and acquired disorders which result in obstruction of the bladder, necessitate surgical measures (including augmentation); such diagnoses bring a clinical need for effective bladder replacement implant designs. Many recent approaches for the design of soft tissue replacement materials have relied on the use of synthetic polymeric substances; unfortunately, the optimal soft tissue implant material is yet to be found. This may, in part, be because current polymeric formulations fail to sufficiently biomimic the neighboring bladder tissue. This study took a brand new approach in designing the next generation of tissue-engineered bladder constructs through the use of nanotechnology, or materials with nanometer (less than 100 nm) surface features. Results provided evidence that nano-structured polymeric scaffolds (specifically, PLGA and PU) created using chemical etching techniques are capable of enhancing the human bladder smooth muscle cell adhesion, proliferation, and the production of extracellular matrix (ECM) proteins. Preliminary in vivo results also speak to the usefulness of such nano-structured materials. In combination, these findings suggest that nano-dimensional PLGA and PU scaffolds are promising replacement materials for the human bladder wall. (Figure Presented)

AB - Bladder cancers requiring radical cystectomy, along with congenital and acquired disorders which result in obstruction of the bladder, necessitate surgical measures (including augmentation); such diagnoses bring a clinical need for effective bladder replacement implant designs. Many recent approaches for the design of soft tissue replacement materials have relied on the use of synthetic polymeric substances; unfortunately, the optimal soft tissue implant material is yet to be found. This may, in part, be because current polymeric formulations fail to sufficiently biomimic the neighboring bladder tissue. This study took a brand new approach in designing the next generation of tissue-engineered bladder constructs through the use of nanotechnology, or materials with nanometer (less than 100 nm) surface features. Results provided evidence that nano-structured polymeric scaffolds (specifically, PLGA and PU) created using chemical etching techniques are capable of enhancing the human bladder smooth muscle cell adhesion, proliferation, and the production of extracellular matrix (ECM) proteins. Preliminary in vivo results also speak to the usefulness of such nano-structured materials. In combination, these findings suggest that nano-dimensional PLGA and PU scaffolds are promising replacement materials for the human bladder wall. (Figure Presented)

KW - Biodegradable

KW - Bladder

KW - In vitro

KW - In vivo

KW - Nanotechnology

UR - http://www.scopus.com/inward/record.url?scp=34547933272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547933272&partnerID=8YFLogxK

U2 - 10.1002/mabi.200600297

DO - 10.1002/mabi.200600297

M3 - Article

VL - 7

SP - 690

EP - 700

JO - Macromolecular Bioscience

JF - Macromolecular Bioscience

SN - 1616-5187

IS - 5

ER -